WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...
For the second time in a week, Zealand Pharma’s weight loss pipeline has delivered mixed results, this time in a Phase 2 ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...
Argenx shares have fallen more than 13% after the surprise futility finding, which overshadowed a mid-stage celiac disease ...
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 9, 2026
Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to ...
With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.
Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...
AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...
Formation Bio today announced that Anirvan Ghosh, PhD, has joined the company as SVP, Head of Translational Sciences. Ghosh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results